Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Hepatitis B and TLL1[original query] |
|---|
| Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. Journal of gastroenterology 2017 Jul . Seko Yuya, Yamaguchi Kanji, Mizuno Naoki, Okuda Keiichiro, Takemura Masashi, Taketani Hiroyoshi, Hara Tasuku, Umemura Atsushi, Nishikawa Taichiro, Moriguchi Michihisa, Yasui Kohichiroh, Kamaguchi Mai, Nishioji Kenichi, Mochizuki Naomi, Kobayashi Masao, Mori Kojiroh, Tanaka Saiyu, Matsuura Kentaro, Tanaka Yasuhito, Itoh Yoshi |
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Gastroenterology 2017 Feb . Matsuura Kentaro, Sawai Hiromi, Ikeo Kazuho, Ogawa Shintaro, Iio Etsuko, Isogawa Masanori, Shimada Noritomo, Komori Atsumasa, Toyoda Hidenori, Kumada Takashi, Namisaki Tadashi, Yoshiji Hitoshi, Sakamoto Naoya, Nakagawa Mina, Asahina Yasuhiro, Kurosaki Masayuki, Izumi Namiki, Enomoto Nobuyuki, Kusakabe Atsunori, Kajiwara Eiji, Itoh Yoshito, Ide Tatsuya, Tamori Akihiro, Matsubara Misako, Kawada Norifumi, Shirabe Ken, Tomita Eiichi, Honda Masao, Kaneko Shuichi, Nishina Sohji, Suetsugu Atsushi, Hiasa Yoichi, Watanabe Hisayoshi, Genda Takuya, Sakaida Isao, Nishiguchi Shuhei, Takaguchi Koichi, Tanaka Eiji, Sugihara Junichi, Shimada Mitsuo, Kondo Yasuteru, Kawai Yusuke, Kojima Kaname, Nagasaki Masao, Tokunaga Katsushi, Tanaka Yasuhito, |
| TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy. Journal of gastroenterology 2019 Apr 54 (4): 339-346. Iio Etsuko, Matsuura Kentaro, Shimada Noritomo, Atsukawa Masanori, Itokawa Norio, Abe Hiroshi, Kato Keizo, Takaguchi Koichi, Senoh Tomonori, Eguchi Yuichiro, Nomura Hideyuki, Yoshizawa Kai, Kang Jong-Hon, Matsui Takeshi, Hirashima Noboru, Kusakabe Atsunori, Miyaki Tomokatsu, Fujiwara Kei, Matsunami Kayoko, Tsutsumi Susumu, Iwakiri Katsuhiko, Tanaka Yasuhi |
| TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals. Journal of viral hepatitis 2019 Jun . Degasperi Elisabetta, Galmozzi Enrico, Facchetti Floriana, Farina Elisa, D'Ambrosio Roberta, Soffredini Roberta, Iavarone Massimo, Lampertico Piet |
| Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis. Seminars in liver disease 2019 Mar . Fujiwara Naoto, Hoshida Yuj |
| Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. Hepatology communications 2020 Feb 4 (2): 255-267. Kiso Ayumi, Toba Yukiko, Tsutsumi Susumu, Deguchi Sayaka, Igai Keisuke, Koshino Saki, Tanaka Yasuhito, Takayama Kazuo, Mizuguchi Hiroyu |
| Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals. IUBMB life 2020 Dec . Mangoud Nadia O M, Ali Sahar A, El Kassas Mohamed, Soror Sameh |
| The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection. Biomedical reports 2022 1 16 (2): 9. Matsumoto Kosuke, Miyaaki Hisamitsu, Fukushima Masanori, Sasaki Ryu, Haraguchi Masafumi, Miuma Satoshi, Nakao Kazuhi |
| Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals. Clinical and experimental hepatology 2023 1 8 (4): 330-334. Kamal Ahmed, Mohsin Ali Kareem, Matta Cecil, Ghazy Ramy Mohamed, Elhadidi Abeer, Tahoun Mona, Rahal Amr, Domiaty Donia, Mohamed Ne |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: